On episode #32 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 6/21 – 7/4/23.

Hosts: Daniel Griffin and Sara Dong

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of Puscast!

Links for this episode

• Clinical characteristics and outcomes among travelers with severe dengue (AIM)
• Phase 3 randomized trial of Bulevirtide in chronic hepatitis D (NEJM)
• Increased peripheral inflammation associated with structural brain changes and reduced blood flow in virologically controlled people with HIV (JID)
• Sustained viral suppression with dolutegravir monotherapy over 192 weeks in HIV patients (CID)
• Side-by-side comparative study of the immunogenicity of the intramuscular and intradermal rabies post-exposure prophylaxis regimens in suspected RABV exposed individuals (CID)
• Reliability of admission procalcitonin testing for capturing bacteremia across the sepsis spectrum (CCM)
• Early discontinuation of antibiotics in patients admitted with clinically suspected serious infection but negative cultures (OFID)
• Short-course therapy for urinary tract infections in children (JAMA)
• Autochthonous Leprosy in the United States (NEJM)
• Management of pediatric pneumonia (CID)
• Added value of (1,3)-β-D-glucan for the diagnosis of Invasive candidiasis in ICU patients (Infection)
• Selection for insecticide resistance can promote Plasmodium falciparum infection in Anopheles (PLOS Pathogens)
• Locally acquired malaria cases identified in the US (CDC)
• Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens (NN)

Music is by Ronald Jenkees